Skip to main content
. 2019 Sep 16;55:73–80. doi: 10.29390/cjrt-2019-010

Table 1. Demographic, personal, and employment characteristics of respondents (n = 123).

Characteristics No. (%) Respiratory Therapists, (n = 87) Other respiratory professionals (n = 36) Overall n = 123 p
Gender
Female 73 (83.9) 35 (97.2) 108 (87.8) NA
Male 14 (16.1) 1 (2.8) 15 (12.2) NA
Geographic location
Western Canada 39 (44.8) 19 (52.8) 58 (50.1) 0.61
Ontario 30 (34.5) 12 (28.6) 42 (34.1) 0.61
Atlantic Canada 18 (20.7) 5 (13.9) 23 (18.7) 0.61
Distance to urban centre of >250,000
Located in urban centre 22 (25.3) 13 (36.1) 35 (28.5) 0.35
<250 km 42 (48.3) 17 (47.2) 59 (48.0) 0.35
≥250 km 23 (26.4) 6 (16.7) 29 (23.6) 0.35
Has personal experience with serious illness or death of someone close 70 (80.5) 15 (79.0) 98 (79.7) 0.46
Self-rated importance of spirituality
Somewhat important or important 48 (56.5) 24 (66.7) 72 (58.5) 0.40
Neutral 18 (21.2) 4 (11.1) 22 (17.8) 0.40
Somewhat unimportant or unimportant 19 (22.4) 8 (22.2) 27 (21.9) 0.40
Years of professional experience
≤10 years 13 (14.9) 8 (22.2) 21 (17.1) 0.41
11–25 years 47 (54.0) 15 (41.7) 62 (50.4) 0.41
≥25 years 27 (31.0) 13 (36.1) 40 (32.5) 0.41
Is a Certified Respiratory Educator 76 (88.4) 16 (84.2) 105 (86.1) 0.26
Has attended workshops or professional education on palliative care 32 (36.8) 18 (51.4) 50 (40.7) 0.26
Practice setting
Asthma/COPD/ Cough Clinic 21 (24.1) 3 (8.3) 24 (19.5) NA
Primary health care 11 (12.6) 10 (27.8) 21 (17.1) NA
Acute care 17 (19.5) 4 (11.1) 21 (17.1) NA
Home Care 7 (8.0) 3 (8.3) 10 (8.1) NA
Community Care 6 (6.9) 2 (5.6) 8 (6.5) NA
Other (including: mixed acute care and community, pharmacies, private practice) 25 (28.7) 14 (38.9) 39 (30.1) NA
Primary patient populations seen in practice (multiple allowed)
Chronic cough 86 (98.9) 36 (100) 122 (99.2) NA
COPD 86 (98.9) 34 (94.4) 120 (97.6) NA
Interstitial Lung Disease 58 (66.7) 18 (50.0) 76 (61.8) NA
Asthma 42 (48.3) 21 (58.3) 63 (52.3) NA
Lung Cancer 33 (37.9) 15 (41.7) 48 (39.0) NA
Pulmonary Hypertension 21 (24.1) 6 (16.7) 27 (22.0) NA
Lung Transplant 14 (16.1) 3 (8.3) 17 (13.8) NA
Cystic Fibrosis 8 (9.2) 1 (2.8) 9 (6.5) NA

Note: NA, not available as cell counts of <5 precluded statistical analyses.